Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma

Journal of Clinical Pathology - Molecular Pathology

Volumn 53, Issue 4, 2000, Pages 184-187

  Mendes Da Silva, P ^a   Moreira, A ^b   Duro Da Costa, J ^c   Matias, D ^c   Monteiro, C ^a  

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

Chromosome 5; Loss of heterozygosity; Non small cell lung carcinoma

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME 5; CLINICAL ARTICLE; GENE DELETION; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOMES, HUMAN, PAIR 5; DNA, NEOPLASM; GENE DELETION; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MICROSATELLITE REPEATS;

EID: 0012905718     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.53.4.184     Document Type: Article

References (23)

1. 1 Giaccone G. Oncogenes and antioncogenes in lung tumori-genesis. Chest 1996;109:130S-4S.
2. 2 Tavassoli M, Steingrimsdottir H, Pierce E, et al. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. Br J Cancer 1996;74:115-19.
3. 3 Tamura G, Ogasawara S, Nishizuka S, et al. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res 1996;56:612-15.
4. 4 Ogasawara S, Tamura G, Maesawa C, et al. Common deleted region on the long arm of chromosome 5 in esophageal carcinoma. Gastroenterology 1996;110:52-7.
5. 5 Horrigan SK, Westbrook CA, Kim AH, et al. Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood 1996;88:2665-70.
6. 6 Ashton-Rickardt PG, Wyllie AH, Bird CC, et al. MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer. Oncogene 1991;6:1881-6.
7. 7 D'Amico D, Carbone DP, Johnson BE, et al. Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. Cancer Res 1992;52:1996-9.
8. 8 Hosoe S, Uen K, Shigedo Y, et al. A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung. Cancer Res 1994;54:1787-90.
9. 9 Fong KM, Zimmerman PV, Smith J. Microsatellite instability and other molecular abnormalities in non-small cell lung cancer. Cancer Res 1995;55:28-30.
10. 10 Benachenhou N, Guiral S, Gorska-Flipot I, et al. High resolution deletion mapping reveals frequent allelic losses at the DNA mismatch repair loci hMLH1 and hMSH3 in non-small-cell lung cancer. Int J Cancer 1998;77:173-80.
11. 11 Wieland I, Böhm M, Arden KC, et al. Allelic deletion mapping on chromosome 5 in human lung carcinomas. Oncogene 1996;12:97-102.
12. 12 Wu X, Zhao Y, Kemp BL, et al. Chromosome 5 aberrations and genetic predisposition to lung cancer. Int J Cancer 1998;79:490-3.
13. 13 Ziegle JS, Su Y, Corcoran KP, et al. Application of automated DNA sizing technology for genotyping microsatellite loci. Genomics 1992;14:1026-31.
14. 14 Cawkwell L, Bell SM, Lewis FA, et al. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 1993;67:1262-7.
15. 15 Marsh DJ, Zheng Z, Zedenius J, et al. Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas. Cancer Res 1997;57:500-3.
16. 16 Conde AR, Martins G, Saraiva C, et al. Association of p53 genomic instability with the glutathione S-transferase null genotype in gastric cancer in the Portuguese population. J Clin Pathol: Mol Pathol 1999;52:131-4.
17. 17 Peralta RC, Casson AG, Wang R, et al. Distinct regions of frequent loss of heterozygosity of chromosome 5p and 5q in human esophageal cancer. Int J Cancer 1998;78:600-5.
18. 18 Achille A, Baron A, Zamboni G, et al. Chromosome 5 allelic losses are early events in tumours of the papilla of Vater and occur at sites similar to those of gastric cancer. Br J Cancer 1998;78:1653-60.
19. 19 Cooper CA, Bubb VJ, Smithson N, et al. Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of ape mutation. J Pathol 1996;180:33-7.
20. 20 Ueno K, Kumagai T, Kijima T, et al. Cloning and tissue expression of cDNAs from chromosome 5q21 - 22 which is frequently deleted in advanced lung cancer. Hum Genet 1998;102:63-8.
21. 21 Le Beau MM, Espinosa III R, Neuman WL, et al. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Natl Acad Sci U S A 1993;90:5484-8.
22. 22 Harada H, Willison K, Sakakibara J, et al. Absence of the type-I IFN system in EC cells: transcriptional activator (IRF-1) and represser (IRF-2) genes are developmentally regulated. Cell 1990;63:303-12.
23. 23 Nozawa H, Oda E, Ueda S, et al. Functionally inactivating point mutation in the tumour-suppressor IRF-1 gene identified in human gastric cancer. Int J Cancer 1998;77:522-7.